JR, C., & KS, M. (2025). Metabolic dysfunction and insulin sensitizers in acute and chronic disease. Expert opinion on investigational drugs, 34(1-2), 17. https://doi.org/10.1080/13543784.2025.2463086
Chicago Style (17th ed.) CitationJR, Colca, and McCommis KS. "Metabolic Dysfunction and Insulin Sensitizers in Acute and Chronic Disease." Expert Opinion on Investigational Drugs 34, no. 1-2 (2025): 17. https://doi.org/10.1080/13543784.2025.2463086.
MLA (9th ed.) CitationJR, Colca, and McCommis KS. "Metabolic Dysfunction and Insulin Sensitizers in Acute and Chronic Disease." Expert Opinion on Investigational Drugs, vol. 34, no. 1-2, 2025, p. 17, https://doi.org/10.1080/13543784.2025.2463086.
Warning: These citations may not always be 100% accurate.
